Mmmmm.....
- results from both stages of the ARDS trial by end of August
- next quarterly announcing a record quarter for the company (end of July)
- interim decision by the TGA on over-the-counter sales of Cannabis by 9th September 2020 (https://www.dlapiper.com/en/australia/insights/publications/2020/05/australia-considers-over-the-counter-cbd---snapshot-of-new-proposal/)
- initiation and quite possibly completion of the OSA trial
- commencement of the TBI animal trials potentially this month but more likely next month
Do we think that these may be catalysts for a surge in the SP just in time for options (IHLOB) conversion before the 30 Sept deadline
- Forums
- ASX - By Stock
- IHL
- Ann: IHL commences IHL-675 (ARDS) animal study
Ann: IHL commences IHL-675 (ARDS) animal study, page-61
-
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online